Intravenous Ketamine Treatment for Depression: One-year Retrospective Study from a Tertiary Care Psychiatry Center from India.

ABSTRACT:

Background

Major depressive disorder (MDD) is a debilitating mental health condition characterized by significant morbidity and mortality. The emergence of ketamine infusion therapy has provided a promising, rapidly acting treatment option. We aimed to assess the effectiveness of ketamine infusion therapy as an adjunct treatment in patients with depression and to study the patient's profile undergoing ketamine therapy in a real-world clinical setting.

Methods

This was a retrospective chart review. A total of 28 patients with depression who received ketamine infusion therapy at a tertiary care hospital were included in this retrospective analysis. The Hamilton Depression Rating Scale (HAMD) was utilized to assess depressive symptomatology.

Results

A statistically signi

SUBMITTER: Yadav E 

PROVIDER: S-EPMC12040862 | biostudies-literature | 2025 Apr

REPOSITORIES: biostudies-literature